References
- Jones HW, Jr. Record of the first physician to see Henrietta Lacks at the Johns Hopkins Hospital: history of the beginning of the HeLa cell line. Am J Obstet Gynecol. 1997;176(6):S227–S228. doi:10.1016/S0002-9378(97)70379-X.
- Zur Hausen H. Papillomaviruses in the causation of human cancers—a brief historical account. Virology 2009;384(2):260–265. doi:10.1016/j.virol.2008.11.046.
- Nature Editorial Board. Henrietta Lacks: science must right a historical wrong. Nature 2020;585(7823):7.
- Frazer I. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004;4(1):46–54. doi:10.1038/nri1260.
- Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States—2013–2017. USCS Data Brief, no 18. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services. Available at: https://www.cdc.gov/cancer/uscs/about/data-briefs/no18-hpv-assoc-cancers-UnitedStates-2013-2017.htm. Published 2020.
- McQuillan G, Kruszon-Moran D, Markowitz LE, et al. Prevalence of HPV in adults aged 18–69: United States, 2011–2014. NCHS Data Brief 2017;(280):1–8.
- Gardasil Vaccine Safety. U.S. Food & Drug Administration. Available at: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/gardasil-vaccine-safety.
- Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711–723. doi:10.1056/NEJMoa1405044.
- Castellsagué X, Giuliano AR, Goldstone S, et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine 2015;33(48):6892–6901. doi:10.1016/j.vaccine.2015.06.088.
- Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016;137(3):e20151968. doi:10.1542/peds.2015-1968.
- Gargano JW, Unger ER, Liu G, et al. Prevalence of genital human papillomavirus in males, United States, 2013-2014. J Infect Dis. 2017;215(7):1070–1079. doi:10.1093/infdis/jix057.
- Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/mmwr.mm6832a3.
- Walker TY, Elam-Evans LD, Yankey D, et al . National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(33):718–723. doi:10.15585/mmwr.mm6833a2.
- Hung MC, Williams WW, Lu PJ, et al. Vaccination coverage among adults in the United States, National Health Interview Survey. Available at: https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2017.html. Published 2017.
- Attia AC, Wolf J, Núñez AE. On surmounting the barriers to HPV vaccination: we can do better. Ann Med. 2018;50(3):209–225. doi:10.1080/07853890.2018.1426875.
- Cates JR, Diehl SJ, Crandell JL, et al. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine 2014;32(33):4171–4178. doi:10.1016/j.vaccine.2014.05.044.
- Walling EB, Benzoni N, Dornfeld J, et al. Interventions to improve HPV vaccine uptake: a systematic review. Pediatrics 2016;138(1):e20153863. doi:10.1542/peds.2015-3863.
- Dixon BE, Zimet GD, Xiao S, et al. An educational intervention to improve HPV vaccination: a cluster randomized trial. Pediatrics 2019;143(1):e20181457. doi:10.1542/peds.2018-1457.
- Brewer NT, Hall ME, Malo TL, et al. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics 2017;139(1):e20161764. doi:10.1542/peds.2016-1764.
- Dempsey AF, O’Leary ST . Human papillomavirus vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2S):S23–S27. doi:10.1016/j.acap.2017.09.001.
- Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics 2013;132(6):1037–1046. doi:10.1542/peds.2013-2037.
- Glenn BA, Nonzee NJ, Tieu L, et al. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood. Vaccine 2021;39(25):3435–3444.
- Gerend MA, Murdock C, Grove K. An intervention for increasing HPV vaccination on a university campus. Vaccine 2020;38(4):725–729. doi:10.1016/j.vaccine.2019.11.028.
- . Gardasil 9. U.S. Food & Drug Administration. Available at: https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9.
- Szilagyi PG, Humiston SG, Stephens-Shields AJ, et al. Effect of training pediatric clinicians in human papillomavirus communication strategies on human papillomavirus vaccination rates: a cluster randomized clinical trial. JAMA Pediatr. 2021;e210766.
- Koskan A, Cantley A, Li R, Silvestro K, Helitzer D. College students’ digital media preferences for future HPV vaccine campaigns. J Cancer Educ 2021;1–9.
- Robison SG, Osborn AW. The concordance of parent and child immunization. Pediatrics 2017;139(5):e20162883. doi:10.1542/peds.2016-2883.